Centessa Pharmaceuticals

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company dedicated to discovering and developing transformative medicines for patients. Our most advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders, and an immuno-oncology program centered on our LockBody® technology platform. We firmly believe that each of our programs has the potential to change current treatment paradigms and establish new standards of care.